Your browser doesn't support javascript.
loading
Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus "no vaccination" and versus vaccination with the 23-valent pneumococcal polysaccharide vaccine.
Gouveia, Miguel; Jesus, Gonçalo; Inês, Mónica; Costa, João; Borges, Margarida.
Affiliation
  • Gouveia M; a Católica Lisbon School of Business and Economics , Universidade Católica Portuguesa , Lisboa , Portugal.
  • Jesus G; b Centro de Estudos de Medicina Baseada na Evidência, Faculdade de Medicina , Universidade de Lisboa , Lisboa , Portugal.
  • Inês M; c Health Economics and Outcomes Research, Pfizer Portugal , Porto Salvo , Portugal.
  • Costa J; b Centro de Estudos de Medicina Baseada na Evidência, Faculdade de Medicina , Universidade de Lisboa , Lisboa , Portugal.
  • Borges M; d Laboratório de Farmacologia Clínica e Terapêutica , Faculdade de Medicina da Universidade de Lisboa , Lisbon , Portugal.
Hum Vaccin Immunother ; 15(4): 850-858, 2019.
Article in En | MEDLINE | ID: mdl-30633615
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumococcal Infections / Vaccination / Cost-Benefit Analysis / Pneumococcal Vaccines Type of study: Health_economic_evaluation Limits: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Hum Vaccin Immunother Year: 2019 Type: Article Affiliation country: Portugal
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumococcal Infections / Vaccination / Cost-Benefit Analysis / Pneumococcal Vaccines Type of study: Health_economic_evaluation Limits: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Hum Vaccin Immunother Year: 2019 Type: Article Affiliation country: Portugal